Free Trial

Bridgewater Associates LP Has $13 Million Holdings in Crocs, Inc. (NASDAQ:CROX)

Crocs logo with Consumer Discretionary background

Bridgewater Associates LP increased its stake in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) by 48.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 89,752 shares of the textile maker's stock after acquiring an additional 29,166 shares during the quarter. Bridgewater Associates LP owned about 0.15% of Crocs worth $12,997,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. FMR LLC lifted its position in shares of Crocs by 4.8% in the 3rd quarter. FMR LLC now owns 8,907,591 shares of the textile maker's stock worth $1,289,908,000 after acquiring an additional 406,287 shares during the period. Pacer Advisors Inc. raised its stake in shares of Crocs by 33.8% in the third quarter. Pacer Advisors Inc. now owns 1,459,654 shares of the textile maker's stock valued at $211,372,000 after purchasing an additional 368,557 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in Crocs by 1.3% during the second quarter. Thrivent Financial for Lutherans now owns 901,973 shares of the textile maker's stock worth $131,634,000 after buying an additional 11,986 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Crocs by 12.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 790,225 shares of the textile maker's stock valued at $115,322,000 after buying an additional 89,610 shares during the period. Finally, Van Lanschot Kempen Investment Management N.V. raised its stake in shares of Crocs by 6.7% in the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 521,726 shares of the textile maker's stock valued at $76,141,000 after buying an additional 32,984 shares in the last quarter. 93.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CFO Susan L. Healy acquired 1,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 13th. The stock was acquired at an average cost of $99.70 per share, with a total value of $99,700.00. Following the completion of the purchase, the chief financial officer now directly owns 22,652 shares in the company, valued at approximately $2,258,404.40. This trade represents a 4.62 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John B. Replogle bought 2,240 shares of the business's stock in a transaction on Wednesday, October 30th. The stock was bought at an average cost of $112.60 per share, for a total transaction of $252,224.00. Following the purchase, the director now directly owns 9,304 shares of the company's stock, valued at approximately $1,047,630.40. This trade represents a 31.71 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 2.72% of the company's stock.

Crocs Stock Performance

Shares of Crocs stock remained flat at $105.60 during midday trading on Friday. 759,227 shares of the company were exchanged, compared to its average volume of 1,352,887. The company has a quick ratio of 0.90, a current ratio of 1.43 and a debt-to-equity ratio of 0.82. The company's fifty day moving average is $122.56 and its two-hundred day moving average is $134.83. Crocs, Inc. has a fifty-two week low of $85.71 and a fifty-two week high of $165.32. The firm has a market cap of $6.15 billion, a P/E ratio of 7.63, a price-to-earnings-growth ratio of 1.07 and a beta of 2.01.

Crocs (NASDAQ:CROX - Get Free Report) last released its earnings results on Tuesday, October 29th. The textile maker reported $3.60 EPS for the quarter, beating the consensus estimate of $3.10 by $0.50. Crocs had a return on equity of 49.70% and a net margin of 20.50%. The company had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.05 billion. During the same period last year, the firm earned $3.25 EPS. The business's revenue for the quarter was up 1.6% on a year-over-year basis. Sell-side analysts expect that Crocs, Inc. will post 12.93 earnings per share for the current year.

Analyst Ratings Changes

CROX has been the topic of several recent research reports. UBS Group decreased their target price on shares of Crocs from $146.00 to $122.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 30th. KeyCorp lowered their price objective on Crocs from $155.00 to $150.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 30th. Needham & Company LLC assumed coverage on Crocs in a research report on Friday, November 22nd. They set a "buy" rating and a $116.00 target price for the company. Monness Crespi & Hardt lowered their price target on Crocs from $170.00 to $140.00 and set a "buy" rating on the stock in a research report on Wednesday, October 30th. Finally, Williams Trading raised Crocs from a "hold" rating to a "buy" rating and lifted their price objective for the company from $135.00 to $163.00 in a report on Thursday, August 22nd. Five research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $148.80.

Read Our Latest Research Report on CROX

About Crocs

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Further Reading

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Should you invest $1,000 in Crocs right now?

Before you consider Crocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.

While Crocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines